GR3031458T3 - Amide derivatives and their therapeutic use - Google Patents

Amide derivatives and their therapeutic use

Info

Publication number
GR3031458T3
GR3031458T3 GR990402549T GR990402549T GR3031458T3 GR 3031458 T3 GR3031458 T3 GR 3031458T3 GR 990402549 T GR990402549 T GR 990402549T GR 990402549 T GR990402549 T GR 990402549T GR 3031458 T3 GR3031458 T3 GR 3031458T3
Authority
GR
Greece
Prior art keywords
pct
date nov
fluoro
sec
alkyl
Prior art date
Application number
GR990402549T
Other languages
English (en)
Inventor
David Lee Musso
James Leroy Kelley
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of GR3031458T3 publication Critical patent/GR3031458T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C233/11—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to carbon atoms of an unsaturated carbon skeleton containing six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C17/00—Preparation of halogenated hydrocarbons
    • C07C17/093—Preparation of halogenated hydrocarbons by replacement by halogens
    • C07C17/10—Preparation of halogenated hydrocarbons by replacement by halogens of hydrogen atoms
    • C07C17/14—Preparation of halogenated hydrocarbons by replacement by halogens of hydrogen atoms in the side-chain of aromatic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
    • C07C45/46—Friedel-Crafts reactions
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/52—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen
    • C07C57/58—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/52—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen
    • C07C57/58—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen containing six-membered aromatic rings
    • C07C57/60—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen containing six-membered aromatic rings having unsaturation outside the rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/52—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen
    • C07C57/62—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen containing six-membered aromatic rings and other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/64—Acyl halides
    • C07C57/76—Acyl halides containing halogen outside the carbonyl halide groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/42—Unsaturated compounds containing hydroxy or O-metal groups
    • C07C59/56—Unsaturated compounds containing hydroxy or O-metal groups containing halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/62—Halogen-containing esters
    • C07C69/65—Halogen-containing esters of unsaturated acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/732—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids of unsaturated hydroxy carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
GR990402549T 1994-05-10 1999-10-07 Amide derivatives and their therapeutic use GR3031458T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP94303350 1994-05-10
PCT/GB1995/001040 WO1995030645A1 (en) 1994-05-10 1995-05-09 Amide derivatives and their therapeutic use

Publications (1)

Publication Number Publication Date
GR3031458T3 true GR3031458T3 (en) 2000-01-31

Family

ID=8217701

Family Applications (1)

Application Number Title Priority Date Filing Date
GR990402549T GR3031458T3 (en) 1994-05-10 1999-10-07 Amide derivatives and their therapeutic use

Country Status (26)

Country Link
US (1) US5708033A (el)
EP (1) EP0759026B1 (el)
JP (1) JP3419462B2 (el)
KR (1) KR100361788B1 (el)
CN (1) CN1079788C (el)
AT (1) ATE183496T1 (el)
AU (1) AU702606B2 (el)
BR (1) BR9507677A (el)
CA (1) CA2190009A1 (el)
DE (1) DE69511544T2 (el)
DK (1) DK0759026T3 (el)
ES (1) ES2134472T3 (el)
FI (1) FI964482A (el)
GR (1) GR3031458T3 (el)
HK (1) HK1014532A1 (el)
HU (1) HU219241B (el)
IL (3) IL124966A (el)
MX (1) MX9605458A (el)
MY (1) MY113062A (el)
NO (1) NO308654B1 (el)
NZ (1) NZ285134A (el)
RU (1) RU2145954C1 (el)
SI (1) SI0759026T1 (el)
TW (1) TW340109B (el)
WO (1) WO1995030645A1 (el)
ZA (1) ZA953753B (el)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6391282B1 (en) * 1997-11-10 2002-05-21 Flemington Pharmaceutical Corp. Antihistamine sprays and ointments for relief of delayed contact dermatitis
DE19837069C1 (de) * 1998-08-17 2000-01-05 Bayer Ag Substituierte Zimtsäuren und Zimtsäureester, Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung von substituierten Indanoncarbonsäureestern
WO2002062745A1 (en) * 2001-02-06 2002-08-15 Glaxo Group Limited Use of bicyclic esters or amides for the treatment of diseases responsive to enhanced potassium channel activity
US6956129B2 (en) * 2001-02-16 2005-10-18 Bayer Aktiengesellschaft Polyhalogen-substituted cinnamic acids and cinnamic acid derivatives and a process for the preparation of polyhalogen-substituted cinnamic acids and cinnamic acid derivatives
ES2262567T3 (es) * 2001-03-20 2006-12-01 Schwarz Pharma Ag Nuevo uso de una clase peptidica de compuesto para tratamiento del dolor inflamatorio no neuropatico.
DE60100055T2 (de) 2001-03-21 2003-07-24 Sanol Arznei Schwarz Gmbh Neue Verwendung einer Klasse von Peptidverbindungen zur Behandlung von Allodynie oder andere Arten von chronischen oder Phantomschmerzen
GB0216027D0 (en) * 2002-07-10 2002-08-21 Arachnova Therapeutics Ltd New therapeutic use
US20040048874A1 (en) * 2001-05-22 2004-03-11 Bardsley Hazel Judith New therapeutic use of 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno[2,3-D]pyrimidine
BRPI0406749A (pt) * 2003-01-13 2005-12-20 Dynogen Pharmaceuticals Inc Métodos relacionados ao tratamento de distúrbios fincionais do intestino e composição farmacêutica
EP1734980A1 (en) 2004-04-16 2006-12-27 Schwarz Pharma Ag Use of peptidic compounds for the prophylaxis and treatment of chronic headache
CA2573125A1 (en) 2004-08-27 2006-03-02 Schwarz Pharma Ag Novel use of peptide compounds for treating bone cancer pain, chemotherapy-and nucleoside-induced pain
NZ567108A (en) * 2005-12-20 2011-10-28 Nps Pharma Inc Fluorinated compounds
EA019757B1 (ru) 2006-06-15 2014-06-30 ЮСиБи ФАРМА ГМБХ Фармацевтическая композиция с синергетическим противосудорожным эффектом
RU2522460C1 (ru) * 2013-01-09 2014-07-10 Федеральное государственное бюджетное учреждение высшего профессионального образования "Кемеровский государственный университет" (КемГУ) Способ получения алкенилантрахинонов

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE371190B (el) * 1972-03-24 1974-11-11 Kabi Ab
US3325358A (en) * 1962-06-06 1967-06-13 Merck & Co Inc Method of treating inflammation
NO136750C (no) * 1972-06-19 1977-11-02 Takeda Chemical Industries Ltd Fremgangsm}te for fremstilling av indanderivater
JPS5623982B2 (el) * 1972-12-07 1981-06-03
US5416118A (en) * 1992-04-09 1995-05-16 Schering Corporation Bicyclic amides as inhibitors of acyl-coenzyme A: cholesterol acyl transferase
GB9309621D0 (en) * 1993-05-11 1993-06-23 Wellcome Found Amide derivatives and their therapeutic use

Also Published As

Publication number Publication date
MX9605458A (es) 1998-02-28
EP0759026A1 (en) 1997-02-26
MY113062A (en) 2001-11-30
CN1153510A (zh) 1997-07-02
JPH09512814A (ja) 1997-12-22
NO308654B1 (no) 2000-10-09
FI964482A0 (fi) 1996-11-07
ES2134472T3 (es) 1999-10-01
EP0759026B1 (en) 1999-08-18
DK0759026T3 (da) 2000-02-28
KR100361788B1 (ko) 2003-01-24
HUT76465A (en) 1997-09-29
SI0759026T1 (en) 1999-10-31
WO1995030645A1 (en) 1995-11-16
RU2145954C1 (ru) 2000-02-27
BR9507677A (pt) 1997-08-19
HU9603103D0 (en) 1997-01-28
JP3419462B2 (ja) 2003-06-23
CA2190009A1 (en) 1995-11-16
IL124966A (en) 1999-12-22
NZ285134A (en) 1998-03-25
AU702606B2 (en) 1999-02-25
DE69511544T2 (de) 1999-12-23
NO964750L (no) 1996-11-08
TW340109B (en) 1998-09-11
ATE183496T1 (de) 1999-09-15
DE69511544D1 (de) 1999-09-23
IL113665A0 (en) 1995-08-31
FI964482A (fi) 1996-11-07
AU2413895A (en) 1995-11-29
HK1014532A1 (en) 1999-09-30
US5708033A (en) 1998-01-13
IL124966A0 (en) 1999-01-26
HU219241B (en) 2001-03-28
ZA953753B (en) 1996-11-11
CN1079788C (zh) 2002-02-27
IL113665A (en) 1999-12-22
NO964750D0 (no) 1996-11-08

Similar Documents

Publication Publication Date Title
GB9426103D0 (en) Therapeutic agents
GR3031458T3 (en) Amide derivatives and their therapeutic use
GR3033528T3 (en) Novel piperidine derivatives with paf antagonist activity
HUT76801A (en) 3-substituted 3h-2,3-benzodiazepine derivatives, their preparation and medicaments containing them
GR3021314T3 (en) N-acyl pyrrolidines and drugs for the treatment or prevention of cholecystokinin and gastrin-related disorders.
PL313037A1 (en) Phenoxphenylocyclopententenylohydroxyureas
GR3025050T3 (en) Etoposide derivatives, process for their preparation, their use as a drug and in the preparation of a drug for treating cancer.
TW261605B (el)
HU9502067D0 (en) N-acyl pyrrolidines and drugs for the treatment or prevention of cholecystokinin and gastrin-related disorders